Attached files
| file | filename |
|---|---|
| 10-K - China Botanic Pharmaceutical | v208541_10k.htm |
| EX-3.4 - China Botanic Pharmaceutical | v208541_ex3-4.htm |
| EX-10.3 - China Botanic Pharmaceutical | v208541_ex10-3.htm |
| EX-31.1 - China Botanic Pharmaceutical | v208541_ex31-1.htm |
| EX-31.2 - China Botanic Pharmaceutical | v208541_ex31-2.htm |
| EX-23.1 - China Botanic Pharmaceutical | v208541_ex23-1.htm |
| EX-32.2 - China Botanic Pharmaceutical | v208541_ex32-2.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of China Botanic Pharmaceutical Inc. (the
“Registrant”) on Form 10-K for the Year ended October 31, 2010, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Shaoming Li, chief executive officer and president of the Registrant, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Registrant.
|
|
Dated: January
24, 2011
|
/s/
Shaoming Li
|
|
|
Shaoming
Li
|
||
|
Chief
Executive Officer and President
|
||
|
(Principal
Executive Officer)
|